Oncology & Cancer

Cholesterol levels, not statins, influence colorectal cancer risk

Long-term use of the cholesterol-lowering drugs known as statins does not appear to decrease a patient's risk of colorectal cancer, suggests a new, large case-control study from Penn Medicine researchers published this week ...

Medications

Statins linked to lower aggression in men, but higher in women

Statins are a hugely popular drug class used to manage blood cholesterol levels and reduce the risk of heart disease. Previous studies had raised questions about adverse behavioral changes with statins, such as irritability ...

Health

Taking statins? Don't worry about memory loss, study finds

Cholesterol-lowering statin drugs most likely do not cause short-term memory loss, according to a Rutgers University and University of Pennsylvania study of nearly one million patients - contrary to prior assertions.

Cardiology

Experimental anti-cholesterol drug shows promise

People taking an experimental drug called Repatha (evolocumab) for high cholesterol were half as likely to die or suffer a heart attack or stroke as those taking conventional statins, researchers said Sunday.

Oncology & Cancer

Statins inhibit spread of some cancers in laboratory tests

Cholesterol-lowering drugs appear to be a promising, cost-effective way to reduce the risk of metastases in some cancers, according to laboratory research led by the University of Pittsburgh School of Medicine. Metastases, ...

Medical research

Researchers use iPS cells to show statin effects on diseased bone

Skeletal dysplasia is a group of rare diseases that afflict skeletal growth through abnormalities in bone and cartilage. Its onset hits at the fetal stage and is caused by genetic mutations. A mutation in the gene encoding ...

page 4 from 40